{"id":"https://genegraph.clinicalgenome.org/r/64f52ae7-d5f8-4100-9928-0159d8f09898v1.1","type":"EvidenceStrengthAssertion","dc:description":["*ADSL* was first reported in relation to autosomal recessive adenylosuccinate lyase (ADSL) deficiency in 1984 (PMID: 6150139). ADSL deficiency results in psychomotor retardation, seizures, hypotonia and autistic behaviors, and encompasses a wide phenotypic spectrum with three forms: neonatal fatal, severe (type I) and mild (type II) (PMIDs: 10888601, 18524658, 25112391). ADSL deficiency is diagnosed biochemically by the presence of two compounds, succinylaminoimidazole cardoxamide riboside (SAICAr) and succinyladenosine (S-Ado), that occur as a result of deficient ADSL enzyme function. At least 80 patients with ADSL deficiency have been reported to date with over 50 variants identified, including missense, nonsense, frameshift and in-frame indels (PMIDs: 10888601, 18524658, 25112391). Pathogenic *ADSL* variants result in decreased or impaired ADSL enzyme function, indicating homozygous loss-of-function as the mechanism of pathogenicity. This gene-disease relationship is also supported by biochemical function and functional assays (PMID: 20127976).\n\nIn summary, there is definitive evidence supporting the relationship between *ADSL* and autosomal recessive ADSL deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on September 7, 2020 (SOP Version 7).","ADSL was first reported in association with autosomal recessive adenylosuccinate lyase (ADSL) deficiency in 1984 (PMID: 6150139). ADSL deficiency results in psychomotor retardation, seizures, hypotonia and autistic behaviors, and encompasses a wide phenotypic spectrum with three forms: neonatal fatal, severe (type I) and mild (type II) (PMID: 25112391, 18524658, 10888601). ADSL deficiency is diagnosed biochemically by the presence of two compounds, succinylaminoimidazole cardoxamide riboside (SAICAr) and succinyladenosine (S-Ado), that occur as a result of deficient ADSL enzyme function. At least 80 patients with ADSL deficiency have been reported to date with over 50 variants identified, including missense, nonsense, frameshift and in-frame indels (PMID: 25112391, 18524658, 10888601). Pathogenic ADSL variants result in decreased or impaired ADSL enzyme function, indicating homozygous loss-of-function as the mechanism of disease. The gene-disease association is further supported by biochemical and functional assays (PMID: 20127976). In summary, the ADSL gene is definitively associated with autosomal recessive ADSL deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 09/07/2020 (SOP Version 7)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/64f52ae7-d5f8-4100-9928-0159d8f09898","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2020-09-07T16:00:00.000Z","2020-09-06T22:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-08-18T15:25:13.193Z","role":"Publisher"}],"curationReasonDescription":"","curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84f882ff-19c6-42b9-ba17-418ffc15707f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec7c5fcf-9d2a-4a3e-bbc7-344c147bb54b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":1,"detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"lack of eye contact, cerebral atrophy with hypomyelinisation, psychomotor regression, right-sided hemiplegia","phenotypes":["obo:HP_0025356","obo:HP_0000486","obo:HP_0001250","obo:HP_0001290","obo:HP_0000252"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/84f882ff-19c6-42b9-ba17-418ffc15707f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.1277G>A (p.Arg426His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115565"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f1a62dbb-31ff-4161-a8dc-312318238e59_proband_score_evidence_line","type":"EvidenceLine","dc:description":"p.R426H is a severe variant resulting in compromised enzyme activity","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24f3ca1e-71c4-4ee2-bde5-52581f3dccf9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Patient6","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"","phenotypes":"obo:HP_0001290","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1a62dbb-31ff-4161-a8dc-312318238e59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a"},{"id":"https://genegraph.clinicalgenome.org/r/63af349d-d236-448d-9422-748c117ce5da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.1288G>A (p.Asp430Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA313117"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ed066a2c-9a3c-49be-9837-8e52cab781b4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/352f71f4-cdde-4d3a-8aea-bf1c036f5e7e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Patient2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":1,"detectionMethod":"","phenotypeFreeText":"coma vigil","phenotypes":["obo:HP_0011344","obo:HP_0001250","obo:HP_0002104"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed066a2c-9a3c-49be-9837-8e52cab781b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7447884e-76a8-4237-96bb-54213c7b8771","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.1009C>T (p.Arg337Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA313099"}},{"id":"https://genegraph.clinicalgenome.org/r/b8978ea6-6004-4d28-af02-e9e8798e3cd7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.8C>T (p.Ala3Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411632573"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/51e2678d-70e7-4dba-9b07-954b76ac6f6b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87000e2b-117f-4a26-8be3-534b3b850342","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient6","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":3,"detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"lack of eye contact, cerebral atrophy with hypomyelinisation","phenotypes":["obo:HP_0001250","obo:HP_0001290","obo:HP_0025356"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/51e2678d-70e7-4dba-9b07-954b76ac6f6b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":[{"id":"https://genegraph.clinicalgenome.org/r/79e50607-e2d3-47bd-a10b-b971346f81c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.69C>G (p.Ser23Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411632688"}},{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a"}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f9ecc3c-b6e5-47c0-99d9-5cd00261ca8f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Family4","family":{"id":"https://genegraph.clinicalgenome.org/r/5f9ecc3c-b6e5-47c0-99d9-5cd00261ca8f","type":"Family","rdfs:label":"Family4","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/cac61c24-5cbb-4165-a09d-e880bfc2e064","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient4","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":3,"detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"lack of eye contact","phenotypes":["obo:HP_0011344","obo:HP_0001250","obo:HP_0001290","obo:HP_0002059"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ffbddbdf-bfc6-498e-997c-c8283458c5e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c4104b1b-76a4-4a51-81bd-f1f0935330b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.725C>T (p.Thr242Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/803695"}},{"id":"https://genegraph.clinicalgenome.org/r/7d552a95-3ac0-4779-8e6e-f4939ac7ab03","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.340T>C (p.Tyr114His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA206321"}}]}}},"phenotypeFreeText":"lack of eye contact","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0025356","obo:HP_0001250","obo:HP_0001522","obo:HP_0002059","obo:HP_0011344","obo:HP_0001290"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cac61c24-5cbb-4165-a09d-e880bfc2e064"}},{"id":"https://genegraph.clinicalgenome.org/r/c40284c6-52ae-4c42-bd8b-236a0cdfdca2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Kmoch_ADSL_patients4+5","family":{"id":"https://genegraph.clinicalgenome.org/r/c40284c6-52ae-4c42-bd8b-236a0cdfdca2","type":"Family","rdfs:label":"Kmoch_ADSL_patients4+5","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7e38cbed-f823-4d34-bc99-7213b3650956","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Patient4","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/18d98dd6-2e3c-48eb-b60c-b576a8da10a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8d0aacb8-6a58-4df0-ada6-1a86a6d08afc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.569G>A (p.Arg190Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115568"}},{"id":"https://genegraph.clinicalgenome.org/r/7d552a95-3ac0-4779-8e6e-f4939ac7ab03"}]}}},"phenotypeFreeText":"oligofrenia","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0000718","proband":{"id":"https://genegraph.clinicalgenome.org/r/7e38cbed-f823-4d34-bc99-7213b3650956"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0d715fe7-0256-48d7-bf5a-ff0144e424e7_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6baaa416-d962-4d51-be18-61c3adb81273","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":5,"detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"transient contact disturbances, slight cerebral atrophy mostly in frontal lobes","phenotypes":["obo:HP_0000486","obo:HP_0025356","obo:HP_0001250"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0d715fe7-0256-48d7-bf5a-ff0144e424e7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":[{"id":"https://genegraph.clinicalgenome.org/r/54cbaef6-4f20-40c7-a3ae-a20125254509","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.994G>C (p.Asp332His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/242557"}},{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a"}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d646422c-b672-4ca4-9f5c-13be352d4920_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2799ca27-1dbe-43d8-9138-81c298c95e4c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"transient contact disturbances, slight cerebral atrophy mostly in frontal lobes, poor eye contact","phenotypes":["obo:HP_0025356","obo:HP_0000486","obo:HP_0001250"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d646422c-b672-4ca4-9f5c-13be352d4920_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/6798b1e0-7f60-4410-9cf2-264a0524832b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"p.R426H is a severe variant resulting in compromised enzyme activity","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cb7862d-4070-4481-9507-98209816d4e2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Patient3","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":14,"detectionMethod":"","phenotypes":["obo:HP_0000365","obo:HP_0001250","obo:HP_0001290","obo:HP_0025356"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6798b1e0-7f60-4410-9cf2-264a0524832b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","allele":{"id":"https://genegraph.clinicalgenome.org/r/d494f199-31e3-4f0e-9f65-d6ea000cd43a"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/23337aea-963b-440d-a3ae-bf4142d8c893_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/baa59b20-6242-4ac7-a212-ddffc8b20172","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","rdfs:label":"Patient1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"detectionMethod":"","phenotypes":["obo:HP_0001250","obo:HP_0011344","obo:HP_0001522"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/23337aea-963b-440d-a3ae-bf4142d8c893_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10888601","allele":[{"id":"https://genegraph.clinicalgenome.org/r/671fbcb9-31a2-4a73-9a6b-21276057ba0f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.802G>A (p.Asp268Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10247835"}},{"id":"https://genegraph.clinicalgenome.org/r/38a1c247-bd48-4bc0-bc79-15ccee781504","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.580C>T (p.Arg194Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411641054"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/18d98dd6-2e3c-48eb-b60c-b576a8da10a3_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e38cbed-f823-4d34-bc99-7213b3650956"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ffbddbdf-bfc6-498e-997c-c8283458c5e6_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cac61c24-5cbb-4165-a09d-e880bfc2e064"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/85d080d9-492a-43ff-ab5e-64ec9692c42b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d095d3ef-ea5c-45ab-9713-5c97c0a13c3b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","rdfs:label":"Patient7","ageType":"AgeAtOnset","ageUnit":"Days","detectionMethod":"PCR sequencing of ADSL gene","firstTestingMethod":"PCR","phenotypeFreeText":"lack of eye contact, immature myelinisation","phenotypes":["obo:HP_0025356","obo:HP_0000486","obo:HP_0001250","obo:HP_0001290","obo:HP_0000252"],"previousTesting":true,"previousTestingDescription":"Testing for SAICAr and S-Ado metabolites characteristic of ADSL deficiency in bodily fluids: \"For final diagnosis, a HPLC analysis of urinary and/or CSF S-Ado and SAICAr on Shimadzu 10A Liquid Chromatography System with PDA detector was used.\"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/85d080d9-492a-43ff-ab5e-64ec9692c42b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18524658","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b4eab1a2-c1f6-4833-8aa6-a33cb19ad053","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.643G>C (p.Asp215His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411641467"}},{"id":"https://genegraph.clinicalgenome.org/r/f7cad292-5693-4729-a7c6-2ee7adf65a99","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000026.4(ADSL):c.1052T>C (p.Ile351Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA411645765"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bf41bfa-0bd7-4a1b-8d4c-5cb70417a8a0","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f77616cb-60c7-453e-a260-a41e7a296e80","type":"Finding","dc:description":"ADSL deficiency is characterized by the presence of two dephosphorylated substrates of ADSL, succinylaminoimidazole cardoxamide riboside (SAICAr) and succinyladenosine (S-Ado) in urine, plasma and CSF, which are normally undetectable in healthy individuals","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25112391","rdfs:label":"ADSL enzyme function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d282f565-84e4-4a47-9acc-77ee31bbe9f6_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59173858-ea9c-4520-8f78-ad0df41129d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fef78daa-17c4-431a-a98d-5561a8b3d973","type":"FunctionalAlteration","dc:description":"Expression vectors of 17 different ADSL variants from ADSL deficiency patients were transfected into DH5aF0 IQ competent E. coli cells and ADSL enzyme function was determined based on SAICAR --> AICAR and S-AMP --> AMP; ADSL variants had decreased function compared to wildtype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20127976","rdfs:label":"Decreased enzyme function from patient variants in E. coli"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/54532248-1145-4c6f-b379-0cb85e4ebeec","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd93e0a7-4b7a-4629-bbe6-51e9fef2ed11","type":"FunctionalAlteration","dc:description":"CSF, plasma and urine from ADSL deficiency patients show high levels of SAICAr and S-Ado as a key feature of diagnosis in demonstrating lack of ADSL enzyme function","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25112391","rdfs:label":"SAICAr and S-Ado metabolites in ADSL deficiency patients"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":11311,"specifiedBy":"GeneValidityCriteria7","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/LGAhMJisSuI","type":"GeneValidityProposition","disease":"obo:MONDO_0007068","gene":"hgnc:291","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d282f565-84e4-4a47-9acc-77ee31bbe9f6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}